One would hope it settled on the basis that the DOCA was voluntarily revoked - although more likely it's a side deal between GXY/WAL/Chinese.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
